scholarly journals State Variation in Psychotropic Medication Use by Foster Care Children With Autism Spectrum Disorder

PEDIATRICS ◽  
2009 ◽  
Vol 124 (2) ◽  
pp. e305-e312 ◽  
Author(s):  
D. M. Rubin ◽  
C. Feudtner ◽  
R. Localio ◽  
D. S. Mandell
PEDIATRICS ◽  
2020 ◽  
Vol 145 (Supplement 1) ◽  
pp. S99-S107 ◽  
Author(s):  
Daniela Ziskind ◽  
Amanda Bennett ◽  
Abbas Jawad ◽  
Nathan Blum

2016 ◽  
Vol 47 (1) ◽  
pp. 144-154 ◽  
Author(s):  
Jeanne M. Madden ◽  
Matthew D. Lakoma ◽  
Frances L. Lynch ◽  
Donna Rusinak ◽  
Ashli A. Owen-Smith ◽  
...  

2012 ◽  
Author(s):  
Melissa P. Maye ◽  
Timothy W. Soto ◽  
Frances Martinez-Pedraza ◽  
Deborah K. Anderson ◽  
Catherine Lord ◽  
...  

BJPsych Open ◽  
2018 ◽  
Vol 4 (6) ◽  
pp. 461-466 ◽  
Author(s):  
Rachael C. Cvejic ◽  
Samuel R. C. Arnold ◽  
Kitty-Rose Foley ◽  
Julian N. Trollor

BackgroundChildren and adolescents with autism spectrum disorder (ASD) are a highly medicated group. Few studies have examined the neuropsychiatric profile and patterns of psychotropic medication use among adults with ASD.AimsTo describe and compare the neuropsychiatric profile and psychotropic medication use in a cohort of adults with ASD and non-autistic controls.MethodBaseline data from a survey-based, longitudinal study of adults with ASD in Australia. Participants were 188 adults with ASD and 115 controls aged 25–80 years.ResultsASD was associated with increased odds of psychotropic medication use even when controlling for the presence of any neurological or psychiatric disorder. There were no corresponding indications for 14.4% of psychotropic medications prescribed to adults with ASD.ConclusionsThis study found substantial psychotropic prescribing for adults with ASD. Patterns of psychotropic medication use may reflect prescribing for behavioural indications despite limited evidence to support this practice.Declaration of interestNone.


2021 ◽  
Vol 8 (1) ◽  
pp. 14-18
Author(s):  
Mert Besenek

Objective:   In addition to the core symptoms of Autism Spectrum Disorder (ASD); symptoms such as aggression, self-harm, impulsivity, hyperactivity, anxiety, and mood problems are also often present. Medication use is frequent and studies report that 27-40% of ASD patients use at least one psychotropic medication. We aimed to examine the clinical and sociodemographic features and treatment modalities of ASD patients who were referred to a rural hospital in the last two years. Material and Methods: Age, gender, mean diagnosis age (MDA), type of ASD, psychiatric symptoms, medication (if they use one) types, and doses were recorded for 200 children with ASD (who were referred between August 2018 – August 2020) were retrospectively evaluated. Also, patients who were diagnosed with “childhood autism (CA)” and “other ASD diagnoses” were compared. Results: The majority of the patients were male, the MDA value of the all patients was 4.56 (±2.2) years and there were no significant differences between groups regarding MDA (p = 0.053). Most frequently seen psychiatric symptoms were behavioral (33%) and attention problems (21%) and 52.5% of patients (n=105) were using at least one psychotropic medication. Patients with CA had higher rates of psychotropic medication use (p=0.010) and the most frequently used medication group was antipsychotic drugs (92.4%). Conclusion: Treatment approaches utilized in rural hospitals are in line with the universal trends. However, considerably higher MDA compared to previous studies show that; to provide early diagnosis and better prognosis for ASD patients who live in rural areas, new interventions should be promoted by the local and/or general authorities.


Sign in / Sign up

Export Citation Format

Share Document